Browse > Article
http://dx.doi.org/10.4014/jmb.1801.01016

Anti-Obesity Effects of a Mixture of Fermented Ginseng, Bifidobacterium longum BORI, and Lactobacillus paracasei CH88 in High-Fat Diet-Fed Mice  

Kang, Dayoung (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University)
Li, Zhipeng (Department of Biomedical Science, College of Veterinary Medicine, Oregon State University)
Ji, Geun Eog (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University)
Publication Information
Journal of Microbiology and Biotechnology / v.28, no.5, 2018 , pp. 688-696 More about this Journal
Abstract
Ginseng and probiotics have anti-obesity effects in mice fed a high-fat diet (HFD). Absorption of ginsenoside and colonization of probiotics occur in the intestine. In this study, a mixture of fermented ginseng and two probiotics, Bifidobacterium longum BORI and Lactobacillus paracasei CH88, was administered to HFD-fed mice for 9 weeks. The mixture significantly suppressed weight gain (p < 0.05, n = 8) and lipid deposition in the liver and adipose tissues as well as increased the mice's food intake. The adipocyte size of the adipose tissue was significantly decreased in the mixture-fed group, especially when 0.5% fermented ginseng and $5{\times}10^8/ml$ of the two probiotics were used (p < 0.05, n = 10). The expression of TNF-${\alpha}$ in adipose tissue was efficiently downregulated in the mixture-fed group (p < 0.05, n = 4). The supplement also improved the mice's fasting blood glucose levels (p < 0.05, n = 8) and total cholesterol feces excretion (p < 0.05, n = 8). The mixture of fermented ginseng and B. longum BORI and L. paracasei CH88 could have an anti-obesity effect and suppress lipid deposit in the liver and adipose tissues.
Keywords
Ginseng; lactobacteria; bifidobacteria; anti-obesity; lipid metabolism;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Li Z, Jin H, Oh SY, Ji GE. 2016. Anti-obese effects of two lactobacilli and two bifidobacteria on ICR mice fed on a high fat diet. Biochem. Biophys. Res. Commun. 480: 222-227.   DOI
2 Ku S. 2016. Finding and producing probiotic glycosylases for the biocatalysis of ginsenosides: a mini review. Molecules 21: 645.   DOI
3 Ku S, You H, Park MS, Ji G. 2016. Whole-cell biocatalysis for producing ginsenoside Rd from Rb1 using Lactobacillus rhamnosus GG. J. Microbiol. Biotechnol. 26: 1206-1215.   DOI
4 Ku S, You H, Park M, Ji G. 2015. Effects of ascorbic acid on ${\alpha}$-l-arabinofuranosidase and ${\alpha}$-l-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside. J. Korean Soc. Appl. Biol. Chem. 58: 857-865.   DOI
5 Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T. 1990. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem. Pharm. Bull. 38: 2859.   DOI
6 Ouwehand AC, Kirjavainen PV, Shortt C, Salminen S. 1999. Probiotics: mechanisms and established effects. Int. Dairy J. 9: 43-52.   DOI
7 Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497.
8 Thaler JP, Schwartz MW. 2010. Inflammation and obesity pathogenesis: the hypothalamus heats up. J. Clin. Endocrinol. Metab. 95: 4077.
9 Park MS, Kwon B, Ku S, Ji GE. 2017. The efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus ad031 probiotic treatment in infants with rotavirus infection. Nutrients 9: E887.   DOI
10 Liu W, Zheng Y, Han L, Wang H, Saito M, Ling M, et al. 2008. Saponins (ginsenosides) from stems and leaves of Panax quinquefolium prevented high-fat diet-induced obesity in mice. Phytomedicine 15: 1140-1145.   DOI
11 Yoo SR, Kim YJ, Park DY, Jung UJ, Jeon SM, Ahn YT, et al. 2013. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity 21: 2571-2578.   DOI
12 Yun S, Moon S, Ko S, Im B, Chung S. 2004. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res. 27: 790-796.   DOI
13 Zhang X-L, Wu Y-F, Wang Y-S, Wang X-Z, Piao C-H, Liu J-M, et al. 2017. The protective effects of probiotic-fermented soymilk on high-fat diet-induced hyperlipidemia and liver injury. J. Funct. Foods 30: 220-227.   DOI
14 Park S, Ahn IS, Kwon DY, Ko BS, WK Jun. 2008. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance ${\beta}$-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci. Biotechnol. Biochem. 72: 2815-2823.   DOI
15 Sakakibara K, Shibata Y, Higashi T, Sanada S, Shoji J. 1975. Effect of ginseng saponins on cholesterol metabolism. I. The level and the synthesis of serum and liver cholesterol in rats treated with ginsenosides. Chem. Pharm. Bull. 23: 1009.   DOI
16 Lye HS, Rusul G, Liong MT. 2010. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J. Dairy Sci. 93: 1383-1392.   DOI
17 Andersson U, Branning C, Ahrne S, Molin G, Alenfall J, Onning G, et al. 2010. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef. Microbes 1: 189-196.   DOI
18 Hwang JT, Lee M, Kim M, Kwon DY. 2008. Biological active components found in Panax ginseng improve glucose uptake via AMPK signaling pathway. FASEB J. 22: 683.
19 Zhang L, Virgous C, Si H. 2017. Ginseng and obesity: observations and understanding in cultured cells, animals and humans. J. Nutr. Biochem. 44: 1-10.   DOI
20 Zhang Y, Yu L, Cai W, Fan S, Feng L, Ji G, Huang C. 2014. Protopanaxatriol, a novel PPAR${\gamma}$ antagonist from Panax ginseng, alleviates steatosis in mice. Sci. Rep. 4: 7375.
21 Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, et al. 2015. Effect of strain K21 on high-fat diet-fed obese mice. Evid. Based Complement. Alternat. Med. 2015: 391767.
22 Park Y-H, Kim J-G, Shin Y-W, Kim S-H, Whang K-Y. 2007. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J. Microbiol. Biotechnol. 17: 655-662.
23 Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, Defuria J, Jick Z, et al. 2007. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56: 2910.   DOI
24 Dentin R, Girard J, Postic C. 2005. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87: 81-86.   DOI
25 Crandall DL, Goldstein BM, Huggins F, Cervoni P. 1984. Adipocyte blood flow: influence of age, anatomic location, and dietary manipulation. Am. J. Physiol. 247: R46-R51.
26 Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M, Cinti S. 2008. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 49: 1562.   DOI
27 Dowman JK, Tomlinson JW, Newsome PN. 2010. Pathogenesis of non-alcoholic fatty liver disease. QJM. 103: 71-83.   DOI
28 Lee H, Park D, Yoon M. 2013. Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice. Food Chem. Toxicol. 53: 402-408.   DOI
29 Takemura N, Okubo T, Sonoyama K. 2010. Lactobacillus plantarum strain no. 14 reduces adipocyte size in mice fed high-fat diet. Exp. Biol. Med. 235: 849-856.   DOI
30 Kim SO. 2007. Ginseng saponin-Re and Coix lachrymajobi var. mayuen regulate obesity related genes expressions, TNF-alpha, leptin, lipoprotein lipase and resistin in 3T3-L1 adipocytes. J. Life Sci. 17: 1523-1532.   DOI
31 Oh J, Lee H, Park D, Ahn J, Shin SS, Yoon M. 2012. Ginseng and its active components ginsenosides inhibit adipogenesis in 3T3-L1 cells by regulating MMP-2 and MMP-9. Evid. Based Complement. Alternat. Med. 2012: 265023.
32 Sekiya K, Okuda H, Hotta Y, Arichi S. 1987. Enhancement of adipose differentiation of mouse 3T3-L1 fibroblasts by ginsenosides. Phytother. Res. 1: 58-60.   DOI
33 Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, et al. 2002. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes 51: 30-36.   DOI
34 Choi S-S, Park J, Choi JH. 2014. Revisiting PPAR${\gamma}$ as a target for the treatment of metabolic disorders. BMB Rep. 47: 599.   DOI
35 Masuno H, Kitao H, Okuda H. 1996. Ginsenosides increase secretion of lipoprotein lipase by 3T3-L1 adipocytes. Biosci. Biotechnol. Biochem. 60: 1962-1965.   DOI
36 Shen J, Obin MS, Zhao L. 2012. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34: 39-58.
37 Jung S, Lee M-S, Shin Y, Kim C-T, Kim I-H, Kim YS, et al. 2014. Anti-obesity and anti-inflammatory effects of high hydrostatic pressure extracts of ginseng in high-fat diet induced obese rats. J. Funct. Foods 10: 169-177.   DOI
38 Ku S, Park MS, Ji G, You H. 2016. Review on Bifidobacterium bifidum BGN4: functionality and nutraceutical applications as a probiotic microorganism. Int. J. Mol. Sci. 17: E1544.   DOI